ITGB2 and neoplasm: Characterization of tumor immune cell infiltration in BRCA-ness demonstrated an association with suppressive tumor associated TREM2 macrophages expressing marker genes, such as LILRB4 and ITGB2, which were found to be downregulated by combination therapy.